Skip to main content
Clinical Trials/NCT05061173
NCT05061173CompletedNot Applicable

Compare the Effects of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults

Riphah International University2 sites in 1 country63 target enrollmentStarted: September 10, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
63
Locations
2
Primary Endpoint
Body Mass Index (BMI)

Study Overview

Brief Summary

To compare the effects of aerobic, resistance and combined training in hypertensive obese patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
40 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hypertensive with BP greater than 140/90 mmHg
  • Overweight and obese adults with BMI (25-40)
  • Physically inactive from past 6 months assessed with pedometer. Those with step count of less than 7000 will be included
  • To be able to exercise (6MWT),t hose who completed the test without any symptom

Exclusion Criteria

  • Any active systemic illness that restricts exercise
  • People doing exercise on regular basis
  • Any cardiopulmonary , metabolic and neurological illness

Outcomes

Primary Outcomes

Body Mass Index (BMI)

Time Frame: 6 Week

Changes from the Baseline, Body mass index (BMI) will be calculated as weight (kg)/height (m2). Below 18.5 Underweight 18.5 - 24.9 Healthy Weight 25.0 - 29.9 Overweight 30.0 and Above Obesity

Change in blood lipid profile

Time Frame: 6 Week

Change in plasma total cholesterol, high density lipoproteins cholesterol (HDL), and low density lipoproteins cholesterol (LDL) after each treatment.

Step Count

Time Frame: 6 week

Pedometer is a valid self-report measure of physical activity. Pedometer is used to count the average daily steps. Change from the baseline to 6 week will be compared.

Systolic and diastolic blood pressure

Time Frame: 6 weeks

Changes from the Baseline, Blood pressure is measured through sphygmomanometer

Waist circumference

Time Frame: 6 week

Waist circumference will be measured for abdominal or central fat mass. It is measured in cm at the middle distance between the last floating rib and the iliac crest using a retractable ergonomic measuring tape. Change from the baseline to 6 week will be compared.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials